{"id":4422550,"date":"2025-01-11T23:28:37","date_gmt":"2025-01-12T05:28:37","guid":{"rendered":"https:\/\/myendoconsult.com\/learn\/topics\/osteogenesis-imperfecta\/"},"modified":"2025-01-13T06:22:17","modified_gmt":"2025-01-13T12:22:17","slug":"osteogenesis-imperfecta","status":"publish","type":"oen_topic","link":"https:\/\/myendoconsult.com\/learn\/topics\/osteogenesis-imperfecta\/","title":{"rendered":"Osteogenesis Imperfecta"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">OSTEOGENESIS IMPERFECTA (OI)<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Definition<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Also referred to as &#8220;<strong>brittle bone disease<\/strong>.&#8221;<\/li>\n\n\n\n<li><strong>Rare<\/strong> hereditary connective tissue disorder (~1 case per 200,000 live births).<\/li>\n\n\n\n<li>Marked <strong>variability<\/strong> in clinical presentation:\n<ul class=\"wp-block-list\">\n<li><strong>Moderate to severe<\/strong> forms often present in infancy (fractures with little\/no trauma).<\/li>\n\n\n\n<li><strong>Mild<\/strong> forms may only appear later (adulthood) with premature <a href=\"https:\/\/myendoconsult.com\/learn\/topics\/osteoporosis\/\"  data-wpil-monitor-id=\"272\">osteoporosis<\/a>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Etiology &amp; Genetic Background<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>~90%<\/strong> of cases: Autosomal dominant <strong>germline mutations<\/strong> in <strong>type I collagen genes<\/strong>\u2014<strong>COL1A1<\/strong> and <strong>COL1A2<\/strong>.\n<ul class=\"wp-block-list\">\n<li>Collagen type I is crucial for normal bones, sclerae, tendons, ligaments, teeth, and skin.<\/li>\n\n\n\n<li>Disease can result from <strong>abnormal structure<\/strong> or <strong>reduced production<\/strong> of type I collagen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Mutations in <strong>other collagen-related genes<\/strong> (e.g., encoding cartilage-associated proteins) found in a minority of OI patients.<\/li>\n\n\n\n<li><strong>Intra-familial variability<\/strong>: Patients with the same mutation may have different severities (involving other genetic or environmental factors).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Key Clinical Features<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Recurrent bone fractures<\/strong> (often minimal or no trauma).<\/li>\n\n\n\n<li><strong>Blue sclerae<\/strong> (translucent sclera revealing underlying uveal tissue).<\/li>\n\n\n\n<li><strong>Opalescent teeth<\/strong> (dentinogenesis imperfecta) \u2192 teeth appear grayish or bluish, may be fragile.<\/li>\n\n\n\n<li><strong>Easy bruising<\/strong> of tissues.<\/li>\n\n\n\n<li><strong>Basilar skull deformities<\/strong> with possible neurological complications.<\/li>\n\n\n\n<li><strong>Hearing loss<\/strong> (due to fracture of ossicles or inner ear involvement).<\/li>\n\n\n\n<li><strong>Ligament laxity<\/strong> with hypermobility.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Clinical Subtypes<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Type I OI (Mild)<\/strong>\n<ul class=\"wp-block-list\">\n<li>Typically <strong>mild<\/strong> manifestations:\n<ul class=\"wp-block-list\">\n<li>Infrequent fractures (long bones, ribs).<\/li>\n\n\n\n<li><strong>Normal stature<\/strong>, possible <strong>premature osteoporosis<\/strong>.<\/li>\n\n\n\n<li><strong>Mild scoliosis<\/strong> can occur.<\/li>\n\n\n\n<li><strong>Blue sclerae<\/strong>.<\/li>\n\n\n\n<li>Teeth: normal appearance or opalescent.<\/li>\n\n\n\n<li>Early-onset <strong>hearing loss<\/strong> is common.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Often related to a <strong>COL1A1<\/strong> allele deletion \u2192 <strong>normal collagen structure<\/strong> but <strong>reduced<\/strong> overall production.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Type II OI (Lethal Perinatal)<\/strong>\n<ul class=\"wp-block-list\">\n<li>Multiple severe fractures in utero or at birth.<\/li>\n\n\n\n<li>Typically <strong>fatal<\/strong> shortly after delivery (respiratory failure).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Types III, IV, V, VI, VII, and VIII<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Severe bone fragility<\/strong> with frequent fractures and limb deformities.<\/li>\n\n\n\n<li><strong>Progressive<\/strong> skeletal deformities:\n<ul class=\"wp-block-list\">\n<li>Bowed long bones, scoliosis, <a href=\"https:\/\/myendoconsult.com\/learn\/evaluation-of-short-stature\/\"  data-wpil-monitor-id=\"275\">short stature<\/a>.<\/li>\n\n\n\n<li><strong>Basilar skull<\/strong> changes \u2192 possible nerve compression.<\/li>\n\n\n\n<li><strong>Hearing loss<\/strong> if ossicles are affected.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Joint hypermobility can be present.<\/li>\n\n\n\n<li><strong>Type III<\/strong>: progressive deforming form leading to wheelchair use.<\/li>\n\n\n\n<li><strong>Type IV<\/strong>: somewhat less growth retardation vs. Type III; may have normal sclera.<\/li>\n\n\n\n<li><strong>Type V<\/strong>: \u201cCongenital brittle bones with redundant callus;\u201d no dentinogenesis imperfecta.<\/li>\n\n\n\n<li><strong>Type VI<\/strong>: \u201cCongenital brittle bones with mineralization defect;\u201d accumulation of osteoid in bone tissue.<\/li>\n\n\n\n<li><strong>Type VII<\/strong>: Rare, recessive, with rhizomelia (shortening near proximal limb segments).<\/li>\n\n\n\n<li><strong>Type VIII<\/strong>: Recessive, prolyl 3-hydroxylase 1 deficiency \u2192 severely undermineralized bone matrix.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">Laboratory Findings<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Calcium, phosphorus, PTH<\/strong> often <strong>normal<\/strong> in typical OI.<\/li>\n\n\n\n<li><strong>Hypercalciuria<\/strong> may occur, correlates with disease severity.<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/myendoconsult.com\/learn\/bone-turnover-markers-in-osteoporosis\/\"  data-wpil-monitor-id=\"276\">Bone markers<\/a><\/strong>:\n<ul class=\"wp-block-list\">\n<li><strong>Formation markers<\/strong> (bone-specific alkaline phosphatase, osteocalcin, collagen propeptides) may be low in severe disease (impaired osteoblast function).<\/li>\n\n\n\n<li><strong>Resorption markers<\/strong> (urinary hydroxyproline, N\/C-telopeptide crosslinks) may be high, reflecting increased collagen breakdown.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Bone biopsy<\/strong> typically not necessary; if done, may show:\n<ul class=\"wp-block-list\">\n<li>Disorganized bone architecture.<\/li>\n\n\n\n<li>High turnover with decreased cortical width, trabecular number, and cancellous bone volume.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Differential Diagnosis<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Rickets<\/strong> (various forms).<\/li>\n\n\n\n<li><strong>Child abuse<\/strong> (non-accidental fractures).<\/li>\n\n\n\n<li>Idiopathic juvenile osteoporosis.<\/li>\n\n\n\n<li><strong>Hypophosphatasia<\/strong> (tissue-nonspecific alkaline phosphatase deficiency).<\/li>\n\n\n\n<li><strong>Juvenile <a href=\"https:\/\/myendoconsult.com\/learn\/topics\/paget-disease\/\"  data-wpil-monitor-id=\"273\">Paget disease<\/a><\/strong>.<\/li>\n\n\n\n<li><strong>Fibrous dysplasia<\/strong>, <strong>Ehlers-Danlos<\/strong> syndrome, <strong>Menkes<\/strong> disease, <strong>Cole-Carpenter<\/strong> syndrome.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Diagnosis<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical diagnosis<\/strong>: Recurrent fractures, blue sclerae, family history, dentinogenesis imperfecta, hearing loss.<\/li>\n\n\n\n<li><strong>Genetic testing<\/strong>: Mutational analysis of <strong>COL1A1<\/strong> and <strong>COL1A2<\/strong>.<\/li>\n\n\n\n<li><strong>Skeletal radiographs<\/strong>: May reveal osteopenia, thin cortices, multiple fractures in different healing stages.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Treatment &amp; Management<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Team approach<\/strong>: Genetics, orthopedics, neurology, physical\/occupational therapy, dental, ENT, psychology, endocrinology.<\/li>\n\n\n\n<li><strong>Goals<\/strong>:\n<ul class=\"wp-block-list\">\n<li>Reduce fracture frequency.<\/li>\n\n\n\n<li>Maximize mobility and independence.<\/li>\n\n\n\n<li>Prevent\/managing deformities (e.g., scoliosis).<\/li>\n\n\n\n<li>Control pain.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Monitoring<\/strong>:\n<ul class=\"wp-block-list\">\n<li><strong>Bone mineral density<\/strong> (BMD) with DXA.<\/li>\n\n\n\n<li>Frequency of fractures.<\/li>\n\n\n\n<li>Hearing tests, dental evaluations.<\/li>\n\n\n\n<li>For Type III OI \u2192 annual echocardiogram (to detect aortic root dilation\/valvular issues).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Pharmacologic therapy<\/strong>:\n<ul class=\"wp-block-list\">\n<li><strong>Bisphosphonates<\/strong> (e.g., pamidronate, alendronate) \u2192 shown to increase BMD, decrease fractures, and improve mobility.<\/li>\n\n\n\n<li>Monitor for any \u201cmineralization defect\u201d OI types (e.g., Type VI) where bisphosphonates may be less effective or contraindicated.<\/li>\n\n\n\n<li>Other treatments under investigation: <a href=\"https:\/\/myendoconsult.com\/learn\/evaluation-of-adult-growth-hormone-deficiency\/\"  data-wpil-monitor-id=\"274\">growth hormone<\/a>, gene therapy, bone marrow transplant.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Prognosis<\/strong>:\n<ul class=\"wp-block-list\">\n<li><strong>Type I<\/strong>: Normal life expectancy; mild disease.<\/li>\n\n\n\n<li>More severe forms: Shortened lifespan, linked to thoracic deformities and related complications.<\/li>\n\n\n\n<li>Skilled orthopedic interventions and bracing may reduce complications and improve quality of life.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>OSTEOGENESIS IMPERFECTA (OI) Definition Etiology &amp; Genetic Background Key Clinical Features Clinical Subtypes Laboratory Findings Differential Diagnosis Diagnosis Treatment &amp; Management<\/p>\n","protected":false},"featured_media":0,"template":"","oen_topic_chapter":[687],"class_list":["post-4422550","oen_topic","type-oen_topic","status-publish","hentry","oen_topic_chapter-parathyroid-gland","post-wrapper","thrv_wrapper"],"_links":{"self":[{"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/oen_topic\/4422550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/oen_topic"}],"about":[{"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/types\/oen_topic"}],"version-history":[{"count":3,"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/oen_topic\/4422550\/revisions"}],"predecessor-version":[{"id":4422553,"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/oen_topic\/4422550\/revisions\/4422553"}],"wp:attachment":[{"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/media?parent=4422550"}],"wp:term":[{"taxonomy":"oen_topic_chapter","embeddable":true,"href":"https:\/\/myendoconsult.com\/learn\/wp-json\/wp\/v2\/oen_topic_chapter?post=4422550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}